$75.74
-0.35%Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Last Annual Value
0.00
3-Year CAGR
%
5-Year CAGR
%
10-Year CAGR
%
| Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Henry Schein, Inc. NASDAQ:HSIC | 0.00 | N/A | N/A | N/A | |
![]() Halozyme Therapeutics, Inc. NASDAQ:HALO | 0.00 | N/A | N/A | N/A | |
![]() Globus Medical, Inc. NYSE:GMED | 0.00 | N/A | N/A | N/A | |
![]() Molina Healthcare, Inc. NYSE:MOH | 275.00M | -12.1% | 3.2% | 6.0% | |
![]() Bio-Rad Laboratories, Inc. NYSE:BIO | 0.00 | N/A | N/A | N/A | |
![]() Masimo Corporation NASDAQ:MASI | 0.00 | N/A | N/A | N/A | |
![]() Avantor, Inc. NYSE:AVTR | 145.00M | -13.5% | 0.0% | 17.6% | |
![]() AptarGroup, Inc. NYSE:ATR | 0.00 | N/A | N/A | N/A | |
![]() DaVita Inc. NYSE:DVA | 0.00 | N/A | N/A | N/A |
Continue your HSIC research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.